Related Experiment Video
Updated: May 20, 2026

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
Probiotics for chronic constipation: A randomized, prospective, placebo-controlled study.
Ashwin D Porwal1, Paresh M Gandhi1, Deepak K Kulkarni1
1Healing Hands Clinic, Ground Floor, Millennium Star Extension, Pune, Maharashtra, India.
GutBio Plus, a probiotic with Lactobacillus and Bifidobacterium, significantly improved chronic constipation symptoms and quality of life in a clinical trial. It offers a safe and effective alternative to conventional treatments.
Area of Science:
- Gastroenterology
- Microbiome research
- Clinical trial methodology
Background:
- Chronic constipation impacts quality of life and is inadequately managed by conventional treatments.
- A multispecies probiotic, GutBio Plus (Lactobacillus and Bifidobacterium strains), was investigated for its efficacy.
- Open-label, placebo-controlled trials are crucial for evaluating novel constipation therapies.
Purpose of the Study:
- To assess the safety and efficacy of GutBio Plus in managing chronic constipation.
- To evaluate GutBio Plus's impact on complete spontaneous bowel movements (CSBM) and related symptoms.
- To determine the effect of GutBio Plus on patients' quality of life.
Main Methods:
- A single-center, randomized, placebo-controlled trial involving 60 adults with chronic constipation (ROME IV criteria).
- Participants received either GutBio Plus capsules (n=45) or placebo (n=15) for 29 days.
- Primary outcome: proportion achieving ≥3 CSBM/week; secondary outcomes: stool consistency, pain, bloating, and quality of life.
Main Results:
- 100% of GutBio Plus users achieved ≥3 CSBM/week versus 7.69% for placebo (P<.05).
- Significant improvements in abdominal pain, bloating, and stool consistency were observed in the treatment group.
- GutBio Plus users reported marked improvements in quality of life, with sustained benefits post-treatment.
Conclusions:
- GutBio Plus is a safe and effective treatment for chronic constipation.
- It provides significant symptom relief and enhances patients' quality of life.
- GutBio Plus shows potential as a reliable alternative to conventional laxatives.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Probiotics
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...